Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avatrombopag in chemotherapy-induced thrombocytopenia
NCT04609891Completed
- Sponsor
- Anhui Provincial Tumor Hospital
- Start
- May 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of avatrombopag in Thrombocytopenia, sponsored by Anhui Provincial Tumor Hospital. Primary endpoint: Proportion of responders at 2 months. Started May 2020; status: completed.
02
Drugs
avatrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT04609891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04609891.